Invention Grant
- Patent Title: Ophthalmic delivery device and ophthalmic drug compositions
-
Application No.: US16085106Application Date: 2017-03-16
-
Publication No.: US11622884B2Publication Date: 2023-04-11
- Inventor: Robert Steven Bley , Stanley R. Conston , Ronald Yamamoto
- Applicant: Oxular Limited
- Applicant Address: GB Oxford
- Assignee: Oxular Limited
- Current Assignee: Oxular Limited
- Current Assignee Address: GB Oxford
- Agency: Armstrong Teasdale LLP
- International Application: PCT/GB2017/050731 WO 20170316
- International Announcement: WO2017/158366 WO 20170921
- Main IPC: A61F9/00
- IPC: A61F9/00 ; A61K9/16 ; A61K31/573 ; A61K9/00 ; A61K9/50 ; A61K9/70 ; A61K31/165 ; A61K31/192 ; A61K31/196 ; A61K31/407 ; A61K31/436 ; A61K35/28 ; C07K16/24 ; C12N15/113 ; A61M5/19 ; A61M5/315 ; A61M5/32 ; A61M5/20
Abstract:
The present invention provides a cannulation device for administering an active agent containing composition to the suprachoroidal space or supraciliary space. The invention provides methods of treatment of an ocular disease or condition accordingly. The invention also provides compositions for use in a method of treatment of an ocular disease or condition for delivery into the suprachoroidal space or supraciliary space.
Public/Granted literature
- US20200330269A1 Ophthalmic Delivery Device And Ophthalmic Drug Compositions Public/Granted day:2020-10-22
Information query
